Toxicity Following Tranexamic Acid Overdose
- PMID: 38334906
- PMCID: PMC10959844
- DOI: 10.1007/s13181-024-00989-z
Toxicity Following Tranexamic Acid Overdose
Conflict of interest statement
None.
References
-
- Tranexamic acid in sodium chloride. Package Insert. Exela Pharma Sciences, LLC. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212020lbl.pdf. Accessed June 28 2023.
-
- Lysteda. Package Insert. Ferring Pharmaceuticals Inc. 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022430s009lbl.pdf. Accessed June 28 2023.
-
- Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: A randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79. doi: 10.3310/hta17100. - DOI - PMC - PubMed